These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15694690)

  • 21. Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study.
    Sasaki M; Ikeda H; Sato Y; Nakanuma Y
    Free Radic Res; 2008 Jul; 42(7):625-32. PubMed ID: 18608517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of p300 by ATM controls the stability of NBS1.
    Jang ER; Choi JD; Jeong G; Lee JS
    Biochem Biophys Res Commun; 2010 Jul; 397(4):637-43. PubMed ID: 20471956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Yantiri F; Andersen JK
    IUBMB Life; 1999 Aug; 48(2):139-41. PubMed ID: 10794588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of beta-carotene-induced apoptosis of gastric cancer cells: involvement of ataxia-telangiectasia-mutated.
    Jang SH; Lim JW; Kim H
    Ann N Y Acad Sci; 2009 Aug; 1171():156-62. PubMed ID: 19723050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice.
    Kamsler A; Daily D; Hochman A; Stern N; Shiloh Y; Rotman G; Barzilai A
    Cancer Res; 2001 Mar; 61(5):1849-54. PubMed ID: 11280737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron loading and oxidative stress in the Atm-/- mouse liver.
    McDonald CJ; Ostini L; Wallace DF; John AN; Watters DJ; Subramaniam VN
    Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G554-60. PubMed ID: 21292994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.
    Camins A; Pizarro JG; Alvira D; Gutierrez-Cuesta J; de la Torre AV; Folch J; Sureda FX; Verdaguer E; Junyent F; Jordán J; Ferrer I; Pallàs M
    Cell Mol Life Sci; 2010 Nov; 67(22):3865-82. PubMed ID: 20502937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice.
    Erker L; Schubert R; Elchuri S; Huang TT; Tarin D; Mueller K; Zielen S; Epstein CJ; Wynshaw-Boris A
    Free Radic Biol Med; 2006 Aug; 41(4):590-600. PubMed ID: 16863992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?
    Youdim MB
    J Neural Transm Suppl; 2003; (65):73-88. PubMed ID: 12946050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress indices in Parkinson's disease : biochemical determination.
    Youdim MB; Drigues N; Mandel S
    Methods Mol Med; 2001; 62():137-53. PubMed ID: 21318773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late degeneration of nigro-striatal neurons in ATM-/- mice.
    Eilam R; Peter Y; Groner Y; Segal M
    Neuroscience; 2003; 121(1):83-98. PubMed ID: 12946702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice.
    Eilam R; Peter Y; Elson A; Rotman G; Shiloh Y; Groner Y; Segal M
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12653-6. PubMed ID: 9770541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
    Kaur D; Andersen JK
    Aging Cell; 2002 Oct; 1(1):17-21. PubMed ID: 12882349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death.
    Mena NP; García-Beltrán O; Lourido F; Urrutia PJ; Mena R; Castro-Castillo V; Cassels BK; Núñez MT
    Biochem Biophys Res Commun; 2015 Aug; 463(4):787-92. PubMed ID: 26051278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pathopharmacological Interplay between Vanadium and Iron in Parkinson's Disease Models.
    Ohiomokhare S; Olaolorun F; Ladagu A; Olopade F; Howes MR; Okello E; Olopade J; Chazot PL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
    Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
    J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron Chelation Nanoparticles with Delayed Saturation as an Effective Therapy for Parkinson Disease.
    Wang N; Jin X; Guo D; Tong G; Zhu X
    Biomacromolecules; 2017 Feb; 18(2):461-474. PubMed ID: 27989126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease.
    Gotsbacher MP; Telfer TJ; Witting PK; Double KL; Finkelstein DI; Codd R
    Metallomics; 2017 Jul; 9(7):852-864. PubMed ID: 28466891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.